Recall of Medical Products from API Source Nectar Lifesciences Ltd, Unit II, India/سحب المنتجات الطبية المصنعة من مصدر المادة الفعالة نكتار لايف ساينس ليمتد
29 Oct 2025
Reference: CIR-2025-00000197
To all Health facilities and healthcare practitioners in Dubai's private health sector
Referring to the above subject, DHA notifies all health facilities regarding the circulars issued by the MOHAP for perusal and adherence to what is stated.
Recall of Medical Products from API Source Nectar Lifesciences Ltd, Unit II, India
Thanks in advance for your good co-operation
Drug Control Section
Health Regulation Sector
Supporting Documents:
Do you find this Content helpful?